1.15
price down icon10.16%   -0.13
after-market Handel nachbörslich: 1.14 -0.01 -0.87%
loading

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
219.03%
0.855
0.268 0.148 0.099 1.72
Operating Expenses
26.95%
32.16
44.03 35.77 35.18 33.80
Benefits Costs and Expenses
28.66%
28.92
40.53 32.28 32.44 31.78
Costs And Expenses
28.66%
28.92
40.53 32.28 32.44 31.78
Operating Income/Loss
28.46%
-31.31
-43.76 -35.63 -35.08 -32.08
Nonoperating Income/Loss
7.07%
3.248
3.495 3.498 2.736 2.025
Income/Loss From Continuing Operations Before Tax
30.31%
-28.06
-40.27 -32.13 -32.34 -30.06
Income Tax Expense/Benefit
100.12%
0.001
-0.869 0.592 0.95 1.208
Income/Loss From Continuing Operations After Tax
28.77%
-28.06
-39.40 -32.72 -33.29 -31.26
Net Income/Loss
28.77%
-28.06
-39.40 -32.72 -33.29 -31.26
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
27,342%
62.30
0.227 59.45 59.25 58.61
Basic Earnings Per Share
30.77%
-0.45
-0.65 -0.55 -0.56 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
Kapitalisierung:     |  Volumen (24h):